{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:58:44Z","timestamp":1793836724874,"version":"4.6.1"},"reference-count":32,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T00:00:00Z","timestamp":1594080000000},"content-version":"unspecified","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002336","name":"Daiichi Sankyo Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006520","name":"Edwards Lifesciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006520","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2020,5,8]]},"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>There is paucity of data on optimal medical treatment, including use of beta blockers for patients undergoing transcatheter aortic valve replacement (TAVR). The study aimed to investigate the association of beta blockers and clinical outcomes following TAVR.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We examined data of 2563 patients who underwent TAVR between October 2013 and May 2017 obtained from a prospective multicentre cohort registry, the optimised catheter valvular intervention-TAVI registry. We compared the 2-year cardiovascular and non-cardiovascular mortality and in-hospital outcomes between patients with and without preprocedural beta-blocker administration by propensity score matching (PSM).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Preprocedural beta blockers were prescribed in 867 patients (33.8%). After PSM, the incidence of in-hospital congestive heart failure was significantly lower in patients with preprocedural beta blocker (p=0.046). No differences were found in 2-year cardiovascular and non-cardiovascular mortality. In the subgroup analyses, beta-blocker administration was associated with a lower cardiovascular mortality within 2 years in patients with a history of coronary artery bypass grafting (CABG; log-rank p=0.017), presence of peripheral artery disease (PAD; log-rank p=0.003) and brain natriuretic peptide (BNP) \u2265400\u2009pg\/mL (log-rank p=0.003). When stratified by postprocedural left ventricular ejection fraction (post-LVEF), beta-blocker administration was associated with a lower cardiovascular mortality among patients with post-LVEF &lt;50% (log-rank p=0.024).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Preprocedural beta-blocker administration was not associated with 2-year cardiovascular and non-cardiovascular mortality in overall, but was associated with a lower 2-year cardiovascular mortality in patients with a history of CABG, presence of PAD, BNP \u2265400\u2009pg\/mL and post-LVEF &lt;50%. The findings must be validated using randomised trials.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/openhrt-2020-001269","type":"journal-article","created":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T05:17:46Z","timestamp":1594185466000},"page":"e001269","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":28,"title":["Impact of beta blockers on patients undergoing transcatheter aortic valve replacement: the OCEAN-TAVI registry"],"prefix":"10.1136","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5356-9477","authenticated-orcid":false,"given":"Tetsuya","family":"Saito","sequence":"first","affiliation":[{"name":"Cardiology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Yoshijima","sequence":"additional","affiliation":[{"name":"Cardiology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromu","family":"Hase","sequence":"additional","affiliation":[{"name":"Cardiology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7755-5771","authenticated-orcid":false,"given":"Fumiaki","family":"Yashima","sequence":"additional","affiliation":[{"name":"Cardiology, Saiseikai Utsunomiya Hospital, Utsunomiya, Tochigi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikaru","family":"Tsuruta","sequence":"additional","affiliation":[{"name":"Cardiology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Cardiovascular Surgery, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Cardiology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Naganuma","sequence":"additional","affiliation":[{"name":"Cardiology, New Tokyo Hospital, Matsudo, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Mizutani","sequence":"additional","affiliation":[{"name":"Cardiovascular Medicine, Osaka City General Hospital, Osaka, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoharu","family":"Araki","sequence":"additional","affiliation":[{"name":"Cardiology, Saiseikai Yokohama-City Eastern Hospital, Yokohama, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Tada","sequence":"additional","affiliation":[{"name":"Cardiology, Sendai Kosei Hospital, Sendai, Miyagi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Futoshi","family":"Yamanaka","sequence":"additional","affiliation":[{"name":"Cardiology, Shonan Kamakura General Hospital, Kamakura, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Shirai","sequence":"additional","affiliation":[{"name":"Cardiology, Kokura Memorial Hospital, Kitakyushu, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Tabata","sequence":"additional","affiliation":[{"name":"Cardiovascular Surgery, Tokyo Bay Urayasu Ichikawa Iryo Center, Urayasu, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ueno","sequence":"additional","affiliation":[{"name":"Cardiology, Toyama University School of Medicine, Toyama, Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Takagi","sequence":"additional","affiliation":[{"name":"Cardiology, Ogaki Municipal Hospital, Ogaki, Gifu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Higashimori","sequence":"additional","affiliation":[{"name":"Cardiology, Kishiwada Tokushukai Hospital, Kishiwada, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Cardiology, Teikyo University School of Medicine, Itabashi-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5210-6382","authenticated-orcid":false,"given":"Masanori","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Cardiology, Toyohashi Heart Center, Toyohashi, Aichi, Japan"},{"name":"Cardiology, Nagoya Heart Center, Nagoya, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Hayashida","sequence":"additional","affiliation":[{"name":"Cardiology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,7,7]]},"reference":[{"key":"2025081612214926000_7.2.e001269.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.01.063"},{"key":"2025081612214926000_7.2.e001269.2","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-15-0499"},{"key":"2025081612214926000_7.2.e001269.3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijcard.2015.04.083","article-title":"Beta-Blockers can improve survival in medically-treated patients with severe symptomatic aortic stenosis","volume":"190","author":"Rossi","year":"2015","journal-title":"Int J Cardiol"},{"key":"2025081612214926000_7.2.e001269.4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/CIRCIMAGING.117.006557","article-title":"Metoprolol reduces hemodynamic and metabolic overload in asymptomatic aortic valve stenosis patients: a randomized trial","volume":"10","author":"Hansson","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"2025081612214926000_7.2.e001269.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1202277"},{"key":"2025081612214926000_7.2.e001269.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1514616"},{"key":"2025081612214926000_7.2.e001269.7","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1056\/NEJMoa1700456","article-title":"Surgical or transcatheter aortic-valve replacement in intermediate-risk patients","volume":"376","author":"Reardon","year":"2017","journal-title":"N Engl J Med"},{"key":"2025081612214926000_7.2.e001269.8","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","article-title":"Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients","volume":"380","author":"Mack","year":"2019","journal-title":"N Engl J Med"},{"key":"2025081612214926000_7.2.e001269.9","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa1816885","article-title":"Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients","volume":"380","author":"Popma","year":"2019","journal-title":"N Engl J Med"},{"key":"2025081612214926000_7.2.e001269.10","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2017-311738"},{"key":"2025081612214926000_7.2.e001269.11","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1001\/jama.2018.18077","article-title":"Association of renin-angiotensin inhibitor treatment with mortality and heart failure readmission in patients with transcatheter aortic valve replacement","volume":"320","author":"Inohara","year":"2018","journal-title":"JAMA"},{"key":"2025081612214926000_7.2.e001269.12","doi-asserted-by":"publisher","DOI":"10.4244\/EIJV8I7A121"},{"key":"2025081612214926000_7.2.e001269.13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of echocardiography and the European association of cardiovascular imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"2025081612214926000_7.2.e001269.14","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.echo.2017.02.009","article-title":"Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European association of cardiovascular imaging and the American Society of echocardiography","volume":"30","author":"Baumgartner","year":"2017","journal-title":"J Am Soc Echocardiogr"},{"key":"2025081612214926000_7.2.e001269.15","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000019121.91548.C2"},{"key":"2025081612214926000_7.2.e001269.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejheart.2008.07.014"},{"key":"2025081612214926000_7.2.e001269.17","article-title":"The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomised trial","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"2025081612214926000_7.2.e001269.18","first-page":"2001","article-title":"Effect of metoprolol CR \/ XL in chronic heart failure\u202f: Metoprolol CR \/ XL Randomised Intervention Trial in Congestive Heart Failure","volume":"353","year":"2001","journal-title":"Lancet"},{"key":"2025081612214926000_7.2.e001269.19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199605233342101"},{"key":"2025081612214926000_7.2.e001269.20","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2015-309101"},{"key":"2025081612214926000_7.2.e001269.21","first-page":"1361","article-title":"The effect of periprocedural beta blocker withdrawal on arrhythmic risk following transcatheter aortic valve replacement","volume":"93","author":"Younis","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"2025081612214926000_7.2.e001269.22","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2466-12-48"},{"key":"2025081612214926000_7.2.e001269.23","first-page":"CD004476","article-title":"Perioperative beta-blockers for preventing surgery-related mortality and morbidity","volume":"3","author":"Blessberger","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"2025081612214926000_7.2.e001269.24","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s00380-018-1166-9","article-title":"Comparison of midterm outcomes of transcatheter aortic valve implantation in patients with and without previous coronary artery bypass grafting","volume":"33","author":"Kawashima","year":"2018","journal-title":"Heart Vessels"},{"key":"2025081612214926000_7.2.e001269.25","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/j.amjcard.2015.09.031","article-title":"Impact of Preprocedural B-type natriuretic peptide levels on the outcomes after transcatheter aortic valve implantation","volume":"116","author":"Abramowitz","year":"2015","journal-title":"Am J Cardiol"},{"key":"2025081612214926000_7.2.e001269.26","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.117.005456"},{"key":"2025081612214926000_7.2.e001269.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2010.09.003"},{"key":"2025081612214926000_7.2.e001269.28","first-page":"644","article-title":"Relationship of the angiographic extent of peripheral arterial disease with coronary artery involvement","volume":"62","author":"Satiroglu","year":"2012","journal-title":"J Pak Med Assoc"},{"key":"2025081612214926000_7.2.e001269.29","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.014209"},{"key":"2025081612214926000_7.2.e001269.30","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.22.2482"},{"key":"2025081612214926000_7.2.e001269.31","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/eurheartj\/ehx564","article-title":"Beta-Blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials","volume":"39","author":"Cleland","year":"2018","journal-title":"Eur Heart J"},{"key":"2025081612214926000_7.2.e001269.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2015.09.002"}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2020-001269","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T19:21:59Z","timestamp":1755372119000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2020-001269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":32,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,7,7]]},"published-print":{"date-parts":[[2020,7]]}},"alternative-id":["10.1136\/openhrt-2020-001269"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2020-001269","relation":{},"ISSN":["2053-3624"],"issn-type":[{"value":"2053-3624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7]]}}}